Tängdén T - Search Results

1

Computational Modeling and Design of New Inhibitors of Carbapenemases: A Discussion from the EPIC Alliance Network.

Dahdouh E, Allander L, Falgenhauer L, Iorga BI, Lorenzetti S, Marcos-Alcalde Í, Martin NI, Martínez-Martínez L, Mingorance J, Naas T, Rubin JE, Spyrakis F, Tängdén T, Gómez-Puertas P. Dahdouh E, et al. Among authors: tangden t. Int J Mol Sci. 2022 Aug 28;23(17):9746. doi: 10.3390/ijms23179746. Int J Mol Sci. 2022. PMID: 36077146 Free PMC article.

2

Introducing the C-reactive protein point-of-care test: A conversation analytic study of primary care consultations for respiratory tract infection.

Lindström AKB, Tängdén T. Lindström AKB, et al. Among authors: tangden t. Soc Sci Med. 2022 Dec;315:115493. doi: 10.1016/j.socscimed.2022.115493. Epub 2022 Nov 2. Soc Sci Med. 2022. PMID: 36423539 Free article.

3

International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists: An executive summary.

Hong LT, Downes KJ, FakhriRavari A, Abdul-Mutakabbir JC, Kuti JL, Jorgensen S, Young DC, Alshaer MH, Bassetti M, Bonomo RA, Gilchrist M, Jang SM, Lodise T, Roberts JA, Tängdén T, Zuppa A, Scheetz MH. Hong LT, et al. Among authors: tangden t. Pharmacotherapy. 2023 Aug;43(8):736-739. doi: 10.1002/phar.2844. Pharmacotherapy. 2023. PMID: 37615244 Review.

4

Population Pharmacokinetic and Pharmacodynamic Analysis of Valganciclovir for Optimizing Preemptive Therapy of Cytomegalovirus Infections in Kidney Transplant Recipients.

Cojutti PG, Heffernan AJ, Tängdén T, Della Siega P, Tascini C, Roberts JA, Pea F. Cojutti PG, et al. Among authors: tangden t. Antimicrob Agents Chemother. 2023 Mar 16;67(3):e0166522. doi: 10.1128/aac.01665-22. Epub 2023 Feb 23. Antimicrob Agents Chemother. 2023. PMID: 36815856 Free PMC article.

5

[Carbapenem-resistant Escherichia coli now exist in Sweden].

Ljungquist O, Kjölvmark C, Tängdén T. Ljungquist O, et al. Among authors: tangden t. Lakartidningen. 2013 Aug 7-20;110(32-33):1401-2. Lakartidningen. 2013. PMID: 23980379 Swedish. No abstract available.

6

Evaluation of In Vitro Activity of Double-Carbapenem Combinations against KPC-2-, OXA-48- and NDM-Producing Escherichia coli and Klebsiella pneumoniae.

Allander L, Vickberg K, Lagerbäck P, Sandegren L, Tängdén T. Allander L, et al. Among authors: tangden t. Antibiotics (Basel). 2022 Nov 17;11(11):1646. doi: 10.3390/antibiotics11111646. Antibiotics (Basel). 2022. PMID: 36421290 Free PMC article.

7

Activity of polymyxin B combinations against genetically well-characterised Klebsiella pneumoniae producing NDM-1 and OXA-48-like carbapenemases.

Olsson A, Allander L, Shams A, Al-Farsi H, Lagerbäck P, Tängdén T. Olsson A, et al. Among authors: tangden t. Int J Antimicrob Agents. 2023 Nov;62(5):106967. doi: 10.1016/j.ijantimicag.2023.106967. Epub 2023 Sep 15. Int J Antimicrob Agents. 2023. PMID: 37716575 Free article.

8

Interactions of Polymyxin B in Combination with Aztreonam, Minocycline, Meropenem, and Rifampin against Escherichia coli Producing NDM and OXA-48-Group Carbapenemases.

Olsson A, Hong M, Al-Farsi H, Giske CG, Lagerbäck P, Tängdén T. Olsson A, et al. Among authors: tangden t. Antimicrob Agents Chemother. 2021 Nov 17;65(12):e0106521. doi: 10.1128/AAC.01065-21. Epub 2021 Sep 13. Antimicrob Agents Chemother. 2021. PMID: 34516251 Free PMC article.

9

Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control.

Tängdén T, Giske CG. Tängdén T, et al. J Intern Med. 2015 May;277(5):501-12. doi: 10.1111/joim.12342. Epub 2015 Jan 27. J Intern Med. 2015. PMID: 25556628 Free article. Review.

10

Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments.

Tängdén T, Hickman RA, Forsberg P, Lagerbäck P, Giske CG, Cars O. Tängdén T, et al. Antimicrob Agents Chemother. 2014;58(3):1757-62. doi: 10.1128/AAC.00741-13. Epub 2014 Jan 6. Antimicrob Agents Chemother. 2014. PMID: 24395223 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

62 results

Search Page